|
The
Food and Drug Administration (FDA) is taking steps to
remove phenylpropanolamine (PPA) from all drug products.
All drug companies have been requested to discontinue
marketing products containing PPA. The FDA has also
issued a public health advisory concerning phenylpropanolamine
hydrochloride, an ingredient used in many over-the-counter
(OTC) and prescription cough and cold medications as
a decongestant and in OTC weight loss products.
A
study from the Yale University School of Medicine reports
that taking PPA increases the risk of hemorrhagic stroke
(bleeding into the brain or into tissue surrounding
the brain) in women. Men may also be at risk. The FDA
recommends that consumers not use any products that
contain PPA.
FDA’s
Nonprescription Drugs Advisory Committee recently determined
that there is an association between PPA and hemorrhagic
stroke. It recommended that PPA be considered not safe
for over-the-counter use.
Ephedra,
also known as ma huang, is a herb that is chemically
close to PPA. It is used as an appetite suppressent
and for upper respiratory tract infections. Since 1994,
the Food and Drug Administration has received reports
of more than 40 deaths associated with ephedra supplements,
and approximately 900 bad reactions ranging from dizziness
and nausea to psychosis, seizures, heart attacks and
strokes.
Please
review the type of strokes
that may be caused by PPA and the drugs that contain
PPA. If you think you or someone close to you was affected
then protect your rights and contact us today. You may
be entitled to a CASH AWARD! Call toll free 1-800-562-3362.
Please
review this list of drugs that contain PPA.
|
